當前位置：首頁 SCI期刊 SCIE期刊醫學中科院1區 JCRQ1 期刊介紹(非官網)

Advanced Drug Delivery ReviewsSCIE

國際簡稱：ADV DRUG DELIVER REV 參考譯名：先進的藥物輸送審查

中科院分區
1區
CiteScore分區
Q1
JCR分區
Q1

基本信息：: ISSN：0169-409X; E-ISSN：1872-8294; 是否OA：未開放; 是否預警：否; TOP期刊：是

出版信息：: 出版地區：NETHERLANDS; 出版商：Elsevier; 出版語言：English; 出版周期：Monthly; 出版年份：1987; 研究方向：藥學-醫學

評價信息：: 影響因子：15.2; H-index：278; CiteScore指數：28.1; SJR指數：3.411; SNIP指數：2.46

發文數據：: Gold OA文章占比：31.54%; 研究類文章占比：0.57%; 年發文量：174; 自引率：0.0496...; 開源占比：0.1785; 出版撤稿占比：0; 出版國人文章占比：0.07; OA被引用占比：0.0807...

投稿咨詢加急見刊

英文簡介期刊介紹 CiteScore數據中科院SCI分區 JCR分區發文數據常見問題

英文簡介Advanced Drug Delivery Reviews期刊介紹

The aim of the Journal is to provide a forum for the critical analysis of advanced drug and gene delivery systems and their applications in human and veterinary medicine. The Journal has a broad scope, covering the key issues for effective drug and gene delivery, from administration to site-specific delivery.

In general, the Journal publishes review articles in a Theme Issue format. Each Theme Issue provides a comprehensive and critical examination of current and emerging research on the design and development of advanced drug and gene delivery systems and their application to experimental and clinical therapeutics. The goal is to illustrate the pivotal role of a multidisciplinary approach to modern drug delivery, encompassing the application of sound biological and physicochemical principles to the engineering of drug delivery systems to meet the therapeutic need at hand. Importantly the Editorial Team of ADDR asks that the authors effectively window the extensive volume of literature, pick the important contributions and explain their importance, produce a forward looking identification of the challenges facing the field and produce a Conclusions section with expert recommendations to address the issues.

Articles review the current status of a specific topic, giving equal emphasis to the identification of major conceptual and technological challenges to successful drug and gene delivery, to an evaluation of triumphs as well as shortcomings in current conceptual and technical approaches, and to a discussion of their possible solution.

期刊簡介Advanced Drug Delivery Reviews期刊介紹

《Advanced Drug Delivery Reviews》自1987出版以來，是一本醫學優秀雜志。致力于發表原創科學研究結果，并為醫學各個領域的原創研究提供一個展示平臺，以促進醫學領域的的進步。該刊鼓勵先進的、清晰的闡述，從廣泛的視角提供當前感興趣的研究主題的新見解，或審查多年來某個重要領域的所有重要發展。該期刊特色在于及時報道醫學領域的最新進展和新發現新突破等。該刊近一年未被列入預警期刊名單，目前已被權威數據庫SCIE收錄，得到了廣泛的認可。

該期刊投稿重要關注點：

預計審稿時間：一般,3-8周約15.1周
國際TOP期刊
醫學
PHARMACOLOGY & PHARMACY
SCIE
中科院1區
非預警

Cite Score數據（2024年最新版）Advanced Drug Delivery Reviews Cite Score數據

CiteScore：28.1
SJR：3.411
SNIP：2.46

學科類別	分區	排名	百分位
大類：Pharmacology, Toxicology and Pharmaceutics 小類：Pharmaceutical Science	Q1	1 / 183	99%

CiteScore 是由Elsevier(愛思唯爾)推出的另一種評價期刊影響力的文獻計量指標。反映出一家期刊近期發表論文的年篇均引用次數。CiteScore以Scopus數據庫中收集的引文為基礎，針對的是前四年發表的論文的引文。CiteScore的意義在于，它可以為學術界提供一種新的、更全面、更客觀地評價期刊影響力的方法，而不僅僅是通過影響因子(IF)這一單一指標來評價。

歷年Cite Score趨勢圖

中科院SCI分區Advanced Drug Delivery Reviews 中科院分區

中科院 2023年12月升級版 綜述期刊：是 Top期刊：是

大類學科	分區	小類學科	分區
醫學	1區	PHARMACOLOGY & PHARMACY 藥學	1區

中科院分區表 是以客觀數據為基礎，運用科學計量學方法對國際、國內學術期刊依據影響力進行等級劃分的期刊評價標準。它為我國科研、教育機構的管理人員、科研工作者提供了一份評價國際學術期刊影響力的參考數據，得到了全國各地高校、科研機構的廣泛認可。

中科院分區表 將所有期刊按照一定指標劃分為1區、2區、3區、4區四個層次，類似于“優、良、及格”等。最開始，這個分區只是為了方便圖書管理及圖書情報領域的研究和期刊評估。之后中科院分區逐步發展成為了一種評價學術期刊質量的重要工具。

歷年中科院分區趨勢圖

JCR分區Advanced Drug Delivery Reviews JCR分區

2023-2024 年最新版

按JIF指標學科分區	收錄子集	分區	排名	百分位
學科：PHARMACOLOGY & PHARMACY	SCIE	Q1	4 / 354	99%

按JCI指標學科分區	收錄子集	分區	排名	百分位
學科：PHARMACOLOGY & PHARMACY	SCIE	Q1	7 / 354	98.16%

JCR分區的優勢在于它可以幫助讀者對學術文獻質量進行評估。不同學科的文章引用量可能存在較大的差異，此時單獨依靠影響因子(IF)評價期刊的質量可能是存在一定問題的。因此，JCR將期刊按照學科門類和影響因子分為不同的分區，這樣讀者可以根據自己的研究領域和需求選擇合適的期刊。

歷年影響因子趨勢圖

發文數據

2023-2024 年國家/地區發文量統計

國家/地區數量
USA197
CHINA MAINLAND47
Australia43
England38
GERMANY (FED REP GER)38
France30
Netherlands27
Japan26
Canada17
Denmark15

本刊中國學者近年發表論文

1、Advances in image-guided drug delivery for antibacterial therapy
Author: Huang, Haiyan; Ali, Arbab; Liu, Yi; Xie, Hui; Ullah, Sana; Roy, Shubham; Song, Zhiyong; Guo, Bing; Xu, Jian

Journal: ADVANCED DRUG DELIVERY REVIEWS. 2023; Vol. 192, Issue , pp. -. DOI: 10.1016/j.addr.2022.114634
2、Design strategies and applications of smart optical probes in the second near-infrared window
Author: Chang, Baisong; Chen, Jie; Bao, Jiasheng; Dong, Kangfeng; Chen, Si; Cheng, Zhen

Journal: ADVANCED DRUG DELIVERY REVIEWS. 2023; Vol. 192, Issue , pp. -. DOI: 10.1016/j.addr.2022.114637
3、Radiation-assisted strategies provide new perspectives to improve the nanoparticle delivery to tumor
Author: Zhang, Dongxiao; He, Jian; Zhou, Min

Journal: ADVANCED DRUG DELIVERY REVIEWS. 2023; Vol. 193, Issue , pp. -. DOI: 10.1016/j.addr.2022.114642
4、Nanomaterials and nanomaterials-based drug delivery to promote cutaneous wound healing
Author: Liu, Tengfei; Lu, Yifei; Zhan, Rixing; Qian, Wei; Luo, Gaoxing

Journal: ADVANCED DRUG DELIVERY REVIEWS. 2023; Vol. 193, Issue , pp. -. DOI: 10.1016/j.addr.2022.114670
5、Role of wound microbiome, strategies of microbiota delivery system and clinical management
Author: Tang, Qinghan; Xue, Nannan; Ding, Xiaofeng; Tsai, Kevin H. -Y.; Hew, Jonathan J.; Jiang, Ruihan; Huang, Rizhong; Cheng, Xuxi; Ding, Xiaotong; Cheng, Yuen Yee; Chen, Jun; Wang, Yiwei

Journal: ADVANCED DRUG DELIVERY REVIEWS. 2023; Vol. 192, Issue , pp. -. DOI: 10.1016/j.addr.2022.114671
6、Lysosomal-mediated drug release and activation for cancer therapy and immunotherapy
Author: Sun, Yinping; Sha, Yongjie; Cui, Guanhong; Meng, Fenghua; Zhong, Zhiyuan

Journal: ADVANCED DRUG DELIVERY REVIEWS. 2023; Vol. 192, Issue , pp. -. DOI: 10.1016/j.addr.2022.114624
7、Nanosensitizer-mediated unique dynamic therapy tactics for effective inhibition of deep tumors
Author: Sun, Wenjing; Chu, Chengchao; Li, Shi; Ma, Xiaoqian; Liu, Peifei; Chen, Shileng; Chen, Hongmin

Journal: ADVANCED DRUG DELIVERY REVIEWS. 2023; Vol. 192, Issue , pp. -. DOI: 10.1016/j.addr.2022.114643
8、Protein encapsulation of nanocatalysts: A feasible approach to facilitate catalytic theranostics
Author: Jin, Duo; Liu, Manman; Zhang, Meng; Yu, Wenxin; Yu, Jiaji; Shen, Aizong; Cheng, Junjie; Liu, Yangzhong

Journal: ADVANCED DRUG DELIVERY REVIEWS. 2023; Vol. 192, Issue , pp. -. DOI: 10.1016/j.addr.2022.114648